We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Study of UK-369,003 on the Safety and Efficacy in Patients With COPD

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00163098
Recruitment Status : Completed
First Posted : September 13, 2005
Last Update Posted : October 13, 2006
Information provided by:

September 8, 2005
September 13, 2005
October 13, 2006
December 2004
Not Provided
Effect on exercise tolerance
Same as current
Complete list of historical versions of study NCT00163098 on ClinicalTrials.gov Archive Site
Effect on lung function and quality of life
Same as current
Not Provided
Not Provided
A Study of UK-369,003 on the Safety and Efficacy in Patients With COPD
A Multi-Centre, Multinational, Randomized, Double-Blind, Placebo Controlled, Proof Of Concept Trial To Assess The Effects Of A Subject-Optimized Dose Of UK-369,003 On Exercise Capacity In Subjects With Chronic Obstructive Pulmonary Disease
A randomised, controlled study investigating the effect of UK-369,003 on exercise tolerance in patients with COPD
Not Provided
Phase 1
Phase 2
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment
Pulmonary Disease, Chronic Obstructive
Drug: UK-369,003
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
December 2005
Not Provided

Inclusion Criteria:

  • GOLD criteria 2 to 4
  • 10 pack year history of smoking

Exclusion Criteria:

  • Women of child bearing potential
Sexes Eligible for Study: All
35 Years to 75 Years   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
Argentina,   Australia,   Germany,   India,   United Kingdom
Not Provided
Not Provided
Not Provided
Not Provided
Not Provided
Study Director: Pfizer CT.gov Call Center Pfizer
October 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP